Makers of GLP-1 drugs, including Novo Nordisk and Eli Lilly, are close to releasing pills taken daily to help shed pounds as an alternative to weekly injections.

Eli Lilly's bid for approval for an experimental weight-loss pill got a boost on Wednesday with new clinical trial data, and ...

People with psoriasis might receive unexpected benefits from cutting-edge weight loss drugs like Ozempic and Zepbound, German researchers said in a new study.

It's a trending topic: weight loss medication. But which one might be right for you? 7 News sat down with doctors from Bon ...

Additionally, the biggest near-term risk for weight-loss drugmakers isn’t about demand but operations. Manufacturing of ...

Medical experts discuss whether GLP-1 medications, including Mounjaro and Zepbound, could become comprehensive treatments for ...

The U.S. Food and Drug Administration (FDA) has determined that a promotional video featuring Zepbound and Mounjaro ...

As people come off GLP-1 medications like Ozempic and Wegovy, Virtua Health and other companies are pushing behavior-based ...

Women's telehealth provider Wisp said on Wednesday it has expanded its weight-care offerings to include sale and doorstep ...

Serena Williams has shared a cryptic post on social media about going through some challenging times just a few weeks after ...

Elevance Health Inc. was hit with a proposed class action by a woman who says the insurer wrongly refuses to cover the weight-loss drug Zepbound for patients who need it to treat obstructive sleep ...

Weight-loss drugs such as Wegovy, Zepbound, and other GLP-1 medications are no longer covered for TRICARE For Life (TFL) ...